InVentiv Focuses On Smaller Contracts, Greater Diversification
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharmaceutical services company aims to diversify its mix while preserving contracts with large companies such as J&J and Sanofi-Aventis.
You may also be interested in...
InVentiv Will Redeploy Sanofi-Aventis Reps To Santarus By Year End
Recent acquisitions and contract shifts have broadened the contract sales organization’s revenue base, minimizing loss of Allegra contract, inVentiv CEO Broshy says.
InVentiv Will Redeploy Sanofi-Aventis Reps To Santarus By Year End
Recent acquisitions and contract shifts have broadened the contract sales organization’s revenue base, minimizing loss of Allegra contract, inVentiv CEO Broshy says.
Acomplia Is "Not Approvable" For Smoking Cessation, "Approvable" For Weight Loss
FDA issued a split decision for Sanofi-Aventis' rimonabant NDAs.